Adverum Biotechnologies, Inc.(ADVM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADVM Adverum Biotechnologies, Inc.

交易中 07-10 13:46:49 EDT

2.72

+0.18

+6.89%

最高2.73	最低2.52	成交量10.34万
今开2.53	昨收2.54	日振幅8.27%
总市值5,672万	流通市值3,333万	总股本2,089万
成交额27.35万	换手率0.84%	流通股本1,228万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADVM","market":"US","secType":"STK","nameCN":"Adverum Biotechnologies, Inc.","latestPrice":2.715,"timestamp":1752169592185,"preClose":2.54,"halted":0,"volume":103433,"delay":0,"floatShares":12277508,"shares":20890733,"eps":-7.216385,"marketStatus":"交易中","change":0.175,"latestTime":"07-10 13:46:49 EDT","open":2.53,"high":2.73,"low":2.52,"amount":273506.433838,"amplitude":0.082677,"askPrice":2.73,"askSize":356,"bidPrice":2.7,"bidSize":62,"shortable":3,"etf":0,"ttmEps":-7.216385,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752177600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.54,"preHourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.54,"latestTime":"08:47 EDT","volume":50,"amount":130,"timestamp":1752151672390},"postHourTrading":{"tag":"盘后","latestPrice":2.54,"preClose":2.54,"latestTime":"19:42 EDT","volume":50,"amount":131.66,"timestamp":1752104558144},"volumeRatio":1.275561,"impliedVol":1.163,"impliedVolPercentile":0.748},"requestUrl":"/m/hq/s/ADVM","defaultTab":"news","newsList":[{"id":"2550849621","title":"Adverum Biotechnologies, Inc.盘中异动 急速拉升5.51%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550849621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550849621?lang=zh_cn&edition=full","pubTime":"2025-07-10 22:41","pubTimestamp":1752158488,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日22时41分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅拉升5.51%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Q32 Bio Inc.、Cognition Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Cognition Therapeutics, Inc.、Klotho Neurosciences, Inc.、Nucana Plc较为活跃，换手率分别为331.67%、143.36%、99.72%，振幅较大的相关个股有Cognition Therapeutics, Inc.、Neonc Technologies Holdings, Inc.、Q32 Bio Inc.，振幅分别为73.27%、50.34%、50.33%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710224128a6a1db7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710224128a6a1db7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2549552939","title":"Adverum Biotechnologies, Inc.盘中异动 股价大涨5.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549552939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549552939?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:13","pubTimestamp":1751987607,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日23时13分，Adverum Biotechnologies, Inc.股票出现异动，股价急速拉升5.79%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。其相关个股中，Zyversa Therapeutics, Inc.、Rallybio Corporation、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为1280.05%、544.22%、278.73%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Moleculin Biotech, Inc.，振幅分别为70.96%、70.58%、69.44%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708231327953afd93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708231327953afd93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2548885098","title":"Adverum Biotechnologies, Inc.盘中异动 快速拉升5.12%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548885098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548885098?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:18","pubTimestamp":1751386736,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时18分，Adverum Biotechnologies, Inc.股票出现异动，股价大幅拉升5.12%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。其相关个股中，Neurogene Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1907.86%、1415.55%、207.57%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为69.61%、55.78%、48.00%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001856a4c95625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001856a4c95625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2547097393","title":"Adverum Biotechnologies, Inc.盘中异动 大幅上涨5.17%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097393?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:32","pubTimestamp":1751290335,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时32分，Adverum Biotechnologies, Inc.股票出现波动，股价急速上涨5.17%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2079.66%、113.39%、60.06%，振幅较大的相关个股有Artelo Biosciences, Inc.、Exicure, Inc.、Eyenovia, Inc.，振幅分别为43.74%、16.13%、14.52%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213216a7264320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213216a7264320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2546729692","title":"Adverum Biotechnologies, Inc.盘中异动 临近收盘快速跳水7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729692?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:50","pubTimestamp":1751053813,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅跳水7.23%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。该信息摘要如下：瑞穗银行：维持Adverum Biotechnologies评级，由优于大市调整至优于大市评级, 目标价由16.00美元调整至12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035013a4c1ca8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035013a4c1ca8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2546737206","title":"Adverum Biotechnologies, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546737206","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546737206?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:09","pubTimestamp":1750950590,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日23时09分，Adverum Biotechnologies, Inc.股票出现异动，股价快速下跌5.23%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。该信息摘要如下：瑞穗银行：维持Adverum Biotechnologies评级，由优于大市调整至优于大市评级, 目标价由16.00美元调整至12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626230950a4bf69ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626230950a4bf69ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2546372057","title":"瑞穗银行：维持Adverum Biotechnologies评级，由优于大市调整至优于大市评级, 目标价由16.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546372057","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546372057?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:03","pubTimestamp":1750950212,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Adverum Biotechnologies(ADVM.US)评级，由优于大市调整至优于大市评级, 目标价由16.00美元调整至12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062623073297901617&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062623073297901617&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM"],"gpt_icon":0},{"id":"2545236304","title":"Adverum Biotechnologies, Inc.盘中异动 早盘急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545236304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545236304?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:35","pubTimestamp":1750775720,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时35分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅上涨5.38%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、内克塔治疗、Vor Biopharma Inc.涨幅较大，Nucana Plc、Adial Pharmaceuticals, Inc、Ibio, Inc.较为活跃，换手率分别为685.38%、517.04%、364.31%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Vor Biopharma Inc.、内克塔治疗，振幅分别为176.26%、48.55%、38.68%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223520a4bbacce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624223520a4bbacce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2544530178","title":"Adverum Biotechnologies, Inc.盘中异动 早盘快速拉升10.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544530178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544530178?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:36","pubTimestamp":1750426617,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时36分，Adverum Biotechnologies, Inc.股票出现波动，股价急速上涨10.04%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Dermata Therapeutics Inc C/Wts 、Processa Pharmaceuticals, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Nucana Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为544.62%、171.27%、160.29%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Eyenovia, Inc.，振幅分别为102.34%、27.73%、18.94%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213657a4b4c0cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213657a4b4c0cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2544994306","title":"Adverum Biotechnologies, Inc.盘中异动 大幅下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544994306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544994306?lang=zh_cn&edition=full","pubTime":"2025-06-18 01:00","pubTimestamp":1750179622,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日01时00分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅跳水5.26%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Acurx Pharmaceuticals, Inc.涨幅较大，Cero Therapeutics Holdings, Inc.、Processa Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为8998.47%、4215.16%、2325.58%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Processa Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为450.48%、260.06%、242.28%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618010023a70ebec3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618010023a70ebec3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2543633176","title":"Adverum Biotechnologies, Inc.盘中异动 早盘急速下跌5.02%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543633176","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543633176?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:22","pubTimestamp":1749824544,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时22分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅下挫5.02%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Jasper Therapeutics Inc C/Wts 24/09/2026 、Sol-Gel Technologies Ltd.、Briacell Therapeutics Corp C/Wts 涨幅较大，Nucana Plc、Alzamend Neuro, Inc.、Eyenovia, Inc.较为活跃，换手率分别为625.03%、66.41%、27.58%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.，振幅分别为46.36%、35.79%、31.59%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222224a4a79b3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613222224a4a79b3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2542538941","title":"Adverum Biotechnologies, Inc.盘中异动 早盘急速跳水5.38%报2.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542538941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542538941?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:00","pubTimestamp":1749650400,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时00分，Adverum Biotechnologies, Inc.股票出现波动，股价快速下跌5.38%。截至发稿，该股报2.64美元/股，成交量3.945万股，换手率0.19%，振幅5.92%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611220001977b0da2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611220001977b0da2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2542322513","title":"Adverum Biotechnologies, Inc.盘中异动 下午盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542322513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542322513?lang=zh_cn&edition=full","pubTime":"2025-06-10 03:26","pubTimestamp":1749497212,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日03时26分，Adverum Biotechnologies, Inc.股票出现异动，股价大幅上涨5.12%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Synaptogenix, Inc.、Klotho Neurosciences, Inc.较为活跃，换手率分别为17369.81%、3132.71%、3122.22%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Klotho Neurosciences, Inc.、Citius Pharmaceuticals, Inc.，振幅分别为673.58%、582.93%、175.09%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610032652a7010089&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610032652a7010089&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2541832865","title":"Adverum Biotechnologies, Inc.盘中异动 急速拉升5.99%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541832865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541832865?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:40","pubTimestamp":1749217243,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时40分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅上涨5.99%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Eyenovia, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Nucana Plc涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为1552.42%、559.20%、76.32%，振幅较大的相关个股有Eyenovia, Inc.、Silo Pharma, Inc.、Prime Medicine, Inc.，振幅分别为28.34%、26.33%、16.91%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606214043a6fd4ca4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606214043a6fd4ca4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2540676791","title":"Adverum Biotechnologies, Inc.盘中异动 大幅拉升5.18%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540676791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540676791?lang=zh_cn&edition=full","pubTime":"2025-06-02 22:55","pubTimestamp":1748876152,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日22时55分，Adverum Biotechnologies, Inc.股票出现波动，股价快速上涨5.18%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1502.73%、1035.26%、332.41%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为248.28%、98.58%、80.43%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225552950ba25d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602225552950ba25d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2539269237","title":"Adverum Biotechnologies, Inc.盘中异动 早盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539269237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539269237?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:03","pubTimestamp":1748527388,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时03分，Adverum Biotechnologies, Inc.股票出现波动，股价大幅上涨5.21%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Alzamend Neuro, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Oric Pharmaceuticals, Inc.涨幅较大，Alzamend Neuro, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为6687.34%、505.24%、297.20%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Alzamend Neuro, Inc.、Passage Bio, Inc.，振幅分别为41.13%、40.96%、30.57%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529220308a6f1f863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529220308a6f1f863&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0},{"id":"2537848132","title":"Adverum Biotechnologies, Inc.盘中异动 大幅跳水5.83%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537848132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537848132?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:31","pubTimestamp":1748007077,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时31分，Adverum Biotechnologies, Inc.股票出现异动，股价快速下挫5.83%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体跌幅为0.84%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Imunon, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1048.50%、1041.73%、334.50%，振幅较大的相关个股有Celularity Inc.、Imunon, Inc.、Cardiff Oncology, Inc.，振幅分别为10.44%、9.63%、7.64%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213117aa2c981d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213117aa2c981d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2537923190","title":"Adverum Biotechnologies, Inc.2025财年第一财季实现净利润-47.02百万美元，同比减少89.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537923190","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537923190?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929639,"startTime":"0","endTime":"0","summary":"5月23日，Adverum Biotechnologies, Inc.公布财报，公告显示公司2025财年第一财季净利润为-47.02百万美元，同比减少89.67%；其中营业收入为0.00美元，每股基本收益为-2.25美元。机构评级：截至2025年5月23日，当前有5家机构对Adverum Biotechnologies, Inc.目标价做出预测，其中目标均价为23.00美元，其中最低目标价为4.00美元，最高目标价为33.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000158a6e914a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000158a6e914a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM"],"gpt_icon":0},{"id":"2536646886","title":"Adverum Biotechnologies, Inc.盘中异动 早盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536646886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536646886?lang=zh_cn&edition=full","pubTime":"2025-05-20 22:13","pubTimestamp":1747750425,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日22时13分，Adverum Biotechnologies, Inc.股票出现异动，股价大幅上涨5.41%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃，换手率分别为2031.45%、1376.47%、799.54%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Neuraxis, Inc.，振幅分别为174.55%、95.65%、65.20%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520221345a6e62cb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520221345a6e62cb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADVM","BK4139"],"gpt_icon":0},{"id":"2536443680","title":"Adverum Biotechnologies, Inc.盘中异动 早盘股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536443680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536443680?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:44","pubTimestamp":1747662268,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时44分，Adverum Biotechnologies, Inc.股票出现波动，股价急速下跌5.44%。Adverum Biotechnologies, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、诺瓦瓦克斯医药涨幅较大，Polyrizon Ltd.、Nucana Plc、Brainstorm Cell Therapeutics Inc.较为活跃，换手率分别为7597.87%、2114.42%、694.18%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Brainstorm Cell Therapeutics Inc.、Affimed N.V.，振幅分别为330.19%、31.82%、22.94%。Adverum Biotechnologies, Inc.公司简介：Adverum Biotechnologies Inc是一家临床阶段的公司，旨在建立基因治疗作为一种新的标准，治疗常见的眼部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519214428975e6731&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519214428975e6731&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADVM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adverum.com","stockEarnings":[{"period":"1week","weight":0.1239},{"period":"1month","weight":-0.1448},{"period":"3month","weight":-0.2372},{"period":"6month","weight":-0.4052},{"period":"1year","weight":-0.66},{"period":"ytd","weight":-0.4561}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adverum Biotechnologies, Inc.于2006年7月17号在特拉华州成立。该公司是一家临床阶段基因治疗公司，针对严重罕见和眼部疾病未满足的医疗需求。 利用他们的下一代腺相关病毒（“AAV”）为基础的定向进化平台，他们生成基因治疗产品的候选人，旨在通过诱导治疗性蛋白质的持续表达来提供持久的功效。 他们的核心能力包括临床开发和内部制造专业知识，特别是在工艺开发，检测开发和现行良好生产规范（“cGMP”）质量控制方面。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.160995},{"month":2,"riseRate":0.666667,"avgChangeRate":0.149283},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.074626},{"month":4,"riseRate":0.555556,"avgChangeRate":-0.076068},{"month":5,"riseRate":0.333333,"avgChangeRate":0.109374},{"month":6,"riseRate":0.5,"avgChangeRate":0.019908},{"month":7,"riseRate":0.7,"avgChangeRate":0.04827},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.024367},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.08569},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.079036},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.015621},{"month":12,"riseRate":0.444444,"avgChangeRate":-0.065909}],"exchange":"NASDAQ","name":"Adverum Biotechnologies, Inc.","nameEN":"Adverum Biotechnologies"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adverum Biotechnologies, Inc.(ADVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adverum Biotechnologies, Inc.(ADVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adverum Biotechnologies, Inc.,ADVM,Adverum Biotechnologies, Inc.股票,Adverum Biotechnologies, Inc.股票老虎,Adverum Biotechnologies, Inc.股票老虎国际,Adverum Biotechnologies, Inc.行情,Adverum Biotechnologies, Inc.股票行情,Adverum Biotechnologies, Inc.股价,Adverum Biotechnologies, Inc.股市,Adverum Biotechnologies, Inc.股票价格,Adverum Biotechnologies, Inc.股票交易,Adverum Biotechnologies, Inc.股票购买,Adverum Biotechnologies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adverum Biotechnologies, Inc.(ADVM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adverum Biotechnologies, Inc.(ADVM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}